Abstract
Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 101-106 |
| Number of pages | 6 |
| Journal | Acta Clinica Croatica |
| Volume | 50 |
| Issue number | 1 |
| State | Published - Dec 1 2011 |
Fingerprint
Keywords
- Anticoagulants
- Platelet aggregation inhibitors
- Prevention and control
- Secondary prevention
- Stroke
- Therapeutic use
ASJC Scopus subject areas
- Medicine(all)
Cite this
Rundek, T., Bašić-Kes, V., Morović, S., & Demarin, V. (2011). Update on Antithrombotic Agents in Secondar y Stroke Prevention. Acta Clinica Croatica, 50(1), 101-106.